Condition-specific omega-3 & vitamin nutriceuticals supported by vast clinical research & the world’s leading doctors
Let PRN help support you, your practice, and your patients.
« Return to Patient Site
Your browser can’t play HTML5 video.
Download it instead.
A message from Michael B. Gross, MD, Chief Medical Officer for PRN Physician Recommended Nutriceuticals, and internationally recognized expert in nutritional approaches to health management and disease prevention.
A pilot study of patients with blepharitis treated with omega-3 in the triglyceride form showed that oral treatment resulted in a change in the meibum composition. Furthermore, symptoms, osmolarity, tear break-up time, and blood saturation of omega-3 also improved. This study is in contrast to that of Wojtowicz et. al and Mascai who found no quantifiable change in meibum. One possible explanation for this is the use of omega-3 in the triglyceride form from marine sources rather that omega-3 in the ethyl ester form or alphalinoleic acid which is found in flax seed oil.
Omega-3 essential fatty acids are an important nutrient for growth and development throughout all stages of human life.
Choose a PRN product below to learn more...
Over 20,000 clinical studies have shown the benefits of fish oil (i.e., marine-based omega-3 fatty acids) across a multitude of health conditions. Most Americans, though, still suffer from harmful omega-3 deficiency resulting in between 72,000 and 96,000 preventable deaths each year.*
Click here to learn more about the benefits of omega-3s for your health and the differences between the currently available brands.
* US National Health center for Health Statistics, 2005 data
Though many nutritional supplements including omega-3s are available, PRN Physician Recommended Nutriceuticals provides products with unmatched purity and potency, and the endorsement of the world’s leading doctors and medical thought leaders. In addition, PRN is dedicated to providing products that meet the following high standards:
Click here to learn more about PRN